Viewing Study NCT02259595

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-02-22 @ 4:10 AM
Study NCT ID: NCT02259595
Status: COMPLETED
Last Update Posted: 2015-05-01
First Post: 2014-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
Sponsor: Otologic Pharmaceutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hearing Loss View
None Sensorineural Hearing Loss View
None Noise-Induced Hearing Loss View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hearing Loss View
None Sensorineural Hearing Loss View
None Noise-Induced Hearing Loss View
None Antioxidant View
None NAC View
None N-acetylcysteine View
None HPN-07 View